Clinical Outcomes of Mirogabalin Treatment for Neuropathic Pain Due to Spinal Diseases in Patients Intolerant to Continuous Administration of Pregabalin
Introduction: We often treat patients with peripheral neuropathic pain due to spine diseases with mirogabalin as an alternative to pregabalin because of adverse events or insufficient efficacy associated with pregabalin treatment. However, there have been few reports on the safety and efficacy of mi...
Main Authors: | Takuya Yamanaka, Katsushi Takeshita, Takao Mochizuki, Hirokazu Inoue, Toru Akiyama |
---|---|
Format: | Article |
Language: | English |
Published: |
The Japanese Society for Spine Surgery and Related Research
2023-03-01
|
Series: | Spine Surgery and Related Research |
Subjects: | |
Online Access: | https://www.jstage.jst.go.jp/article/ssrr/7/2/7_2022-0127/_pdf/-char/en |
Similar Items
-
Short-term outcomes of mirogabalin in patients with peripheral neuropathic pain: a retrospective study
by: Tomoko Tetsunaga, et al.
Published: (2020-05-01) -
Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients
by: Mitsuru Sugimoto, et al.
Published: (2021-12-01) -
Long‐term safety and efficacy of mirogabalin in Asian patients with diabetic peripheral neuropathic pain
by: Masayuki Baba, et al.
Published: (2020-05-01) -
Mirogabalin - the use of a new gabapentinoid in the treatment of diabetic neuropathy and postherpetic neuropathy and other conditions
by: Weronika Gawel, et al.
Published: (2023-01-01) -
Mirogabalin for the treatment of diabetic peripheral neuropathic pain: A randomized, double‐blind, placebo‐controlled phase III study in Asian patients
by: Masayuki Baba, et al.
Published: (2019-09-01)